DEL BENE, FRANCESCA
 Distribuzione geografica
Continente #
NA - Nord America 429
EU - Europa 294
AS - Asia 214
Continente sconosciuto - Info sul continente non disponibili 3
Totale 940
Nazione #
US - Stati Uniti d'America 422
CN - Cina 203
IE - Irlanda 109
UA - Ucraina 63
DE - Germania 37
FI - Finlandia 32
SE - Svezia 22
GB - Regno Unito 10
BE - Belgio 8
CA - Canada 7
IT - Italia 7
SG - Singapore 6
EU - Europa 3
FR - Francia 3
GR - Grecia 2
IL - Israele 2
KR - Corea 2
KZ - Kazakistan 1
NL - Olanda 1
Totale 940
Città #
Dublin 107
Chandler 93
Jacksonville 76
Nanjing 55
Beijing 37
Boardman 35
Ann Arbor 31
New York 24
Nanchang 20
Ashburn 19
Tianjin 17
Hebei 16
Princeton 14
Lawrence 13
Medford 12
Wilmington 12
Shenyang 11
Changsha 9
Dearborn 9
Shanghai 9
Brussels 8
Hangzhou 8
Jiaxing 7
Woodbridge 7
Helsinki 6
Kunming 4
Piscataway 4
Singapore 4
Toronto 4
Houston 3
Los Angeles 3
Seattle 3
Milan 2
Netanya 2
Norwalk 2
Verona 2
Washington 2
Winnipeg 2
Zhengzhou 2
Amsterdam 1
Cincinnati 1
Des Moines 1
Fairfield 1
Fuzhou 1
Grugliasco 1
Guangzhou 1
Gunzenhausen 1
Hefei 1
Lanzhou 1
Lodi Vecchio 1
Ningbo 1
Pavia 1
Taizhou 1
Walnut 1
Totale 709
Nome #
A non parametric population approach for selecting biomarkers of a drug action 97
An energy based model able to describe the effect of anticancer drugs on tumor growth and host body weight 87
A PK-PD model of tumor growth after administration of an anti-angiogenic agent given alone or in combination therapies in xenograft mice 82
A new population PK/PD model to assess the myelotoxicity of candidate drugs in preclinical and in clinical studies 77
A predictive pharmacokinetic-pharmacodynamic model of tumor growth kinetics in xenograft mice after administration of anticancer agents given in combination 77
Mathematical models of tumor growth inhibition in xenograft mice after administration of anticancer agents given in combination 73
Study of energetic interactions between the tumor and host to assess the efficacy of an anticancer drug: a new mathematical model 71
A Minimal Model of Tumor Growth Inhibition in Combination Regimens under the Hypothesis of no Interaction between Drugs 70
A tumor growth inhibition model in drugs combination regimens 69
Testing additivity of anticancer agents in pre-clinical studies: A PK/PD modelling approach 68
Statistical methods to detect immune responses to drug administration 64
Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth after administration of an anti-angiogenic agent, bevacizumab, as single-agent and combination therapy in tumor xenografts 59
A model based approach to the in vitro evaluation of anticancer activity 53
Totale 947
Categoria #
all - tutte 2.884
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.884


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020102 0 0 0 15 1 15 7 16 4 25 19 0
2020/2021121 16 12 3 16 0 15 2 16 3 17 18 3
2021/202265 3 2 4 1 2 0 1 5 2 4 11 30
2022/2023272 26 30 0 17 36 19 1 18 109 3 9 4
2023/202498 3 3 9 11 4 39 0 8 0 2 6 13
2024/202522 1 15 4 2 0 0 0 0 0 0 0 0
Totale 947